These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 21317353

  • 1. A view on imaging in drug research and development for respiratory diseases.
    van Echteld CJ, Beckmann N.
    J Pharmacol Exp Ther; 2011 May; 337(2):335-49. PubMed ID: 21317353
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lung MRI for experimental drug research.
    Beckmann N, Cannet C, Karmouty-Quintana H, Tigani B, Zurbruegg S, Blé FX, Crémillieux Y, Trifilieff A.
    Eur J Radiol; 2007 Dec; 64(3):381-96. PubMed ID: 17931813
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Proton magnetic resonance imaging for assessment of lung function and respiratory dynamics.
    Eichinger M, Tetzlaff R, Puderbach M, Woodhouse N, Kauczor HU.
    Eur J Radiol; 2007 Dec; 64(3):329-34. PubMed ID: 17889475
    [Abstract] [Full Text] [Related]

  • 8. Needs for animal models of human diseases of the respiratory system.
    Reid LM.
    Am J Pathol; 1980 Dec; 101(3 Suppl):S89-101. PubMed ID: 6969987
    [Abstract] [Full Text] [Related]

  • 9. Physiology of airway mucus clearance.
    Rubin BK.
    Respir Care; 2002 Jul; 47(7):761-8. PubMed ID: 12088546
    [Abstract] [Full Text] [Related]

  • 10. Emerging drugs for idiopathic pulmonary fibrosis.
    Thannickal VJ, Flaherty KR, Hyzy RC, Lynch JP.
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):707-27. PubMed ID: 16262559
    [Abstract] [Full Text] [Related]

  • 11. Noninvasive structural, functional, and molecular imaging in drug development.
    Rudin M.
    Curr Opin Chem Biol; 2009 Jun; 13(3):360-71. PubMed ID: 19447067
    [Abstract] [Full Text] [Related]

  • 12. Local mucociliary defence mechanisms.
    Chilvers MA, O'Callaghan C.
    Paediatr Respir Rev; 2000 Mar; 1(1):27-34. PubMed ID: 16263440
    [Abstract] [Full Text] [Related]

  • 13. Targeting remodeling in respiratory inflammation.
    Knox AJ, Pang L, Zhu YM.
    Curr Opin Investig Drugs; 2000 Dec; 1(4):428-34. PubMed ID: 11249695
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM, Foidart JM, Noel A, Cataldo DD.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):133-44. PubMed ID: 16487964
    [Abstract] [Full Text] [Related]

  • 16. Role of relaxin in regulation of fibrosis in the lung.
    Tang ML, Samuel CS, Royce SG.
    Ann N Y Acad Sci; 2009 Apr 08; 1160():342-7. PubMed ID: 19416216
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ATP12A promotes mucus dysfunction during Type 2 airway inflammation.
    Lennox AT, Coburn SL, Leech JA, Heidrich EM, Kleyman TR, Wenzel SE, Pilewski JM, Corcoran TE, Myerburg MM.
    Sci Rep; 2018 Feb 01; 8(1):2109. PubMed ID: 29391451
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?
    Restrepo RD.
    Respir Care; 2007 Sep 01; 52(9):1159-73; discussion 1173-5. PubMed ID: 17716384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.